All Updates

Minnesota does well when it comes to passing legislation that prevents and reduces suffering and death from cancer. According to the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality, Minnesota meets benchmarks in key areas of tobacco control.

The 17th edition of the report highlights the areas in which the state can improve polices to reduce suffering and death from cancer, and it highlights the work of the Cancer Prevention and Research Institute of Texas, also known as CPRIT.

Missouri continues to fall short when it comes to passing legislation that prevents and reduces suffering and death from cancer. According to the latest edition of How Do You Measure Up: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality, Missouri is one of the bottom states for tobacco prevention and cessation funding.

While Arkansas has seen improvement in two important cancer-fighting policies, there is still work to be done prevent and reduce suffering and death from cancer.

Wisconsin continues to fall short when it comes to passing legislation that prevents and reduces suffering and death from cancer. According to the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality, Wisconsin still lags behind on tobacco control policies.

Oklahoma’s lawmakers must reject any attempts to weaken or undermine effective tobacco control legislation and implement comprehensive policies that will prevent our kids from developing a lifelong addiction to tobacco.

HELENA, Montana – August 1, 2019 – Montana made progress in the cancer fight by re-authorizing Medicaid this year but fell short when the Legislature did not pass legislation to protect youth from the risk of deadly skin cancer by restricting access to tanning devices for those under the age

Today the Senate Finance Committee is marking up the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, which includes a provision to cap Medicare beneficiaries’ out-of-pocket prescription drug costs in Medicare Part D, among several other proposed changes intended to bring down patient costs.